We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Medical, an emerging medical laser company based in Carlsbad, Calif., was
dragged through lengthy legal action by PhotoMedex, a publicly traded company
based in Pennsylvania with manufacturing facilities in Carlsbad.
Master Bond's newly developed flexible two component epoxy resin system EP21LV
(3/5) has obtained full USP Class VI Certification for the assembly of disposable
and reusable medical devices.
Laboratory Corporation of America (LabCorp) has entered into a new $350 million
senior credit facility with Credit Suisse First Boston and UBS Securities acting
as co-lead arrangers, and a group of seven other financial institutions.
ViOptix, a Fremont, Calif.-based developer and manufacturer of noninvasive local
tissue oxygen measuring devices, has announced that its product, the ODISsey
Tissue Oximeter, has received market clearance from the FDA. Market introduction
of the ODISsey will take place immediately.
IntraLase has announced that Health Canada granted a device license amendment
for the company's IntraLase FS femtosecond laser, which replaces the hand-held
blade historically used to create the corneal flap in LASIK (laser-assisted
in-situ keratomileusis).
Applied Imaging has received 510(k) clearance from the FDA to market its automated
application for Chromosome X and Chromosome Y analysis in bone marrow transplant
patients.
BioSource has announced it was issued U.S. Patent No. 6,818,420, "Methods
of Using Fluorescent Energy Transfer (FET) Labeled Oligonucleotides that includes
a 3'-5' Exonuclease Resistant Quencher Domain and Compositions for Practicing
the Same," by the U.S. Patent and Trademark Office.
Baptist Cancer Services, a division of Mississippi
Baptist Medical Center in Jackson, Miss., acquired the CyberKnife Stereotactic
Radiosurgery System, the only such system approved by the FDA for tumor treatment
anywhere in the body.
St. Jude has completed the acquisition of Endocardial Solutions (ESI) for $11.75
per share in cash consideration which represents an aggregate purchase price
of approximately $272 million.
I-Flow has announced that the FDA cleared its 10-inch ON-Q Soaker Catheter for
the delivery of local anesthetic to the surgical site to reduce pain following
surgery.